PRICE BRANDON (Senior VP Business Development) reported 2 transactions at NASCENT BIOTECH INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/2/2020ACC: 0001477932-20-003735
DirectorOfficer10% Owner· Senior VP Business Development
+3.36M
Net shares
Net buyer
$335.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
3.36M acquired
Non-Derivative Transactions2
Common Stock (conversion of debt to equity)
Direct
Shares
+2.82M
Price / share
$0.10
Trade value
$282.18K
% of position
77.4%
—
3.65M→6.47M
Common Stock
Direct
Shares
+534K
Price / share
$0.10
Trade value
$53.40K
% of position
8.3%
—
6.47M→7M
Total
Net shares
+3.36M
Net value
$335.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock (conversion of debt to equity) Direct | — | J · J | +2.82M | $0.10 | $282.18K | 77.4% | 3.65M | 6.47M |
| Common Stock Direct | — | J · J | +534K | $0.10 | $53.40K | 8.3% | 6.47M | 7M |
| Total | +3.36M | $335.58K | ||||||
Derivative Transactions0
No derivative transactions reported